Table 4

Differences in rates of decline in eGFR (mL·min^-1·1.73 m^-2·yr^-1, mean ± standard error) within genders and between groups when proteinuria was used to define CKD

Health group (n = 4660)

Risk group (n = 8566)

CKD group (n = 341)

Male

(n = 1353)

Female

(n = 3307)

Male

(n = 3836)

Female

(n = 4730)

Male

(n = 130)

Female

(n = 211)

Unadjusted rates of decline in eGFR

0.52 ± 0.04*

0.75 ± 0.03

0.52 ± 0.02*

0.67 ± 0.02

0.97 ± 0.08

0.91 ± 0.07

Covariate-adjusted rates of decline in eGFR^†

0.52 ± 0.04*

0.74 ± 0.04

0.61 ± 0.03*

0.71 ± 0.03

1.03 ± 0.08

0.97 ± 0.10

Covariate-adjusted rates of decline in eGFR^† (referenced to healthy group)

-

-

0.10 ± 0.04&

-0.03 ± 0.04

0.51 ± 0.08&

0.20 ± 0.07&

Gender difference of covariate adjusted rates of decline in eGFR^† (referenced to healthy group)

-

0.09 ± 0.06

0.31 ± 0.10#

Xu et al. BMC Nephrology 2010 11:20   doi:10.1186/1471-2369-11-20